For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Exelixis Inc’s stock clocked out at $21.92, down -6.54% from its previous closing price of $23.46. In other words, the price has decreased by -$6.54 from its previous closing price. On the day, 7.47 million shares were traded. EXEL stock price reached its highest trading level at $22.24 during the session, while it also had its lowest trading level at $20.69.
Ratios:
To gain a deeper understanding of EXEL’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.07. For the most recent quarter (mrq), Quick Ratio is recorded 3.30 and its Current Ratio is at 3.34. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
On December 19, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $27.
On December 15, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $31.Citigroup initiated its Buy rating on December 15, 2023, with a $31 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 21 ’24 when Garber Alan M sold 19,205 shares for $24.01 per share. The transaction valued at 461,112 led to the insider holds 35,703 shares of the business.
Haley Patrick J. sold 47,020 shares of EXEL for $1,008,579 on Feb 23 ’24. The EVP, Commercial now owns 384,866 shares after completing the transaction at $21.45 per share. On Feb 21 ’24, another insider, JOHNSON DAVID EDWARD, who serves as the Director of the company, bought 190,000 shares for $20.70 each. As a result, the insider paid 3,932,734 and bolstered with 1,100,730 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 6386598400 and an Enterprise Value of 5832307200. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.88, and their Forward P/E ratio for the next fiscal year is 14.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.53 while its Price-to-Book (P/B) ratio in mrq is 2.93. Its current Enterprise Value per Revenue stands at 3.158 whereas that against EBITDA is 25.403.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.57, which has changed by 0.12576997 over the last 52 weeks, in comparison to a change of 0.23568535 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $24.34, while it has fallen to a 52-week low of $18.21. The 50-Day Moving Average of the stock is -4.07%, while the 200-Day Moving Average is calculated to be 0.08%.
Shares Statistics:
It appears that EXEL traded 2.22M shares on average per day over the past three months and 2431720 shares per day over the past ten days. A total of 302.79M shares are outstanding, with a floating share count of 286.65M. Insiders hold about 2.76% of the company’s shares, while institutions hold 89.28% stake in the company. Shares short for EXEL as of 1713139200 were 8624543 with a Short Ratio of 3.88, compared to 1710460800 on 8254189. Therefore, it implies a Short% of Shares Outstanding of 8624543 and a Short% of Float of 3.8900003.
Earnings Estimates
The current assessment of Exelixis Inc (EXEL) involves the perspectives of 15.0 analysts closely monitoring its market dynamics.On average, analysts expect EPS of $0.31 for the current quarter, with a high estimate of $0.42 and a low estimate of $0.19, while EPS last year was $0.25. The consensus estimate for the next quarter is $0.3, with high estimates of $0.38 and low estimates of $0.14.
Analysts are recommending an EPS of between $1.36 and $1.04 for the fiscal current year, implying an average EPS of $1.23. EPS for the following year is $1.47, with 14.0 analysts recommending between $2.07 and $1.1.
Revenue Estimates
In the current quarter, 17 analysts expect revenue to total $480.36M. It ranges from a high estimate of $547M to a low estimate of $450M. As of the current estimate, Exelixis Inc’s year-ago sales were $469.85MFor the next quarter, 17 analysts are estimating revenue of $488.09M. There is a high estimate of $539.75M for the next quarter, whereas the lowest estimate is $451M.
A total of 21 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $1.97B, while the lowest revenue estimate was $1.83B, resulting in an average revenue estimate of $1.91B. In the same quarter a year ago, actual revenue was $1.83BBased on 19 analysts’ estimates, the company’s revenue will be $2.07B in the next fiscal year. The high estimate is $2.27B and the low estimate is $1.91B.
